Term ends Sep 30, 2033 · High confidence
20-year base term ends Nov 5, 2032
Held by Smith & Nephew, Inc.
Filed Jan 6, 2017 as application 15/400,557 · Granted Jan 7, 2020
Base term plus 329 days of patent term adjustment (USPTO delay)
Today
2012
2033
Clock starts
Nov 5, 2012
Nov 5, 2012
Term ends
Sep 30, 2033
Sep 30, 2033
Granted
Jan 7, 2020
Jan 7, 2020
base term
patent term adjustment
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
329
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 9,539,115, to Sep 30, 2033. The term already ends on or before that date, so the cap shortened nothing.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 329 days past its 20-year base term on prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 5, 2012, when application 13/669,321, the earliest non-provisional in its chain, was filed (this one was filed Jan 6, 2017) | Nov 5, 2032 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +329 days, USPTO patent term adjustment record | Sep 30, 2033 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 9,539,115) | resolves to Sep 30, 2033, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Sep 30, 2033 | High confidence |
This family
| US 9,539,115 | In force Feb 2035 | Feb 2035 |
| US 10,524,935 | this patent Sep 2033 | Sep 2033 |
| US 11,285,023 | Lapsed on the fee record Mar 2026 | Mar 2026 |
| US 11,850,170 | In force Nov 2032 | Nov 2032 |
| Application 18/389,090 | Abandoned not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 10, 2017 Reel 40921, frame 935 | Coulange, Vincent; Genna, Sophie; Brunnarius, Yann; Lizee, Emmanuel; Perineau, Christophe; Coetzee, Christiaan; Colombier, Jean-alain; Judet, Thierry; Myerson, Mark; Bonnin, Michel | Tornier | Assignment of Assignor's Interest |
| Jan 10, 2017 Reel 40921, frame 944 | Tornier, Inc.; Tornier SAS | Integra Lifesciences Corporation | Assignment of Assignor's Interest |
| Feb 17, 2021 Reel 55280, frame 575 | Integra Lifesciences Corporation | Smith & Nephew, Inc.; Smith & Nephew Orthopaedics AG; Smith & Nephew Asia Pacific Pte. Limited | Assignment of Assignor's Interest |
| Feb 17, 2021 reel/frame not recorded | Integra Lifesciences Corporation | Smith & Nephew, Inc. | Assignment of Assignor's Interest |
| Feb 17, 2021 reel/frame not recorded | Integra Lifesciences Corporation | Smith & Nephew Orthopaedics AG | Assignment of Assignor's Interest |
| Feb 17, 2021 reel/frame not recorded | Integra Lifesciences Corporation | Smith & Nephew Asia Pacific Pte. Limited | Assignment of Assignor's Interest |
| Jun 3, 2021 Reel 56431, frame 422 | Smith & Nephew Asia Pacific Pte. Limited; Smith & Nephew Orthopaedics AG | Smith & Nephew, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Sep 2033
Term ends Sep 30, 2033. Maintenance fees still fall due before then
Note
The 329 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 9,539,115, ends no earlier than this term, so it caps nothing.
Citations
6
later US patents cite this one
That is above the median of utility patents granted in 2020 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.